Search results
Can Unsaturated Fat Boost Muscle in People With Overweight?
Medscape· 1 day agoHigh doses of PUFAs didn't differentially affect lean tissue accumulation in middle-aged individuals...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 4 days agoFasenra is a monoclonal antibody that inhibits the alpha subunit of the interleukin-5 receptor found...
IGF2BP2 regulates the inflammation of fibroblast-like synoviocytes via GSTM5 in rheumatoid arthritis...
Nature· 6 hours agoActivated fibroblast-like synoviocytes (FLSs) play a crucial role in the progression of RA, which release interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α resulting ...
ASLAN expands research on atopic dermatitis treatment By Investing.com
Investing.com· 21 hours agoASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage biopharmaceutical company, has announced a new...
Can Innate Immune System Be Targeted Directly in Lupus?
MedPage Today· 4 days agoAn investigational Toll-like receptor (TLR) antagonist was effective in reducing biomarkers and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day agoNew York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for...
WTNH-TV New Haven· 3 days agoEB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental...
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including...
FOX 59 Indianapolis· 17 hours agoTarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 8 hours agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
Probiotics Emerge as Promising Intervention in Cirrhosis
Medscape· 1 day agoProbiotics appear to be beneficial for patients with cirrhosis, showing a reversal of hepatic encephalopathy (HE), improvement in liver function measures, and regulation of gut dysbiosis, according ...
